Locatelli, L.; Cazzaniga, A.; Fedele, G.; Zocchi, M.; Scrimieri, R.; Moscheni, C.; Castiglioni, S.; Maier, J.A.
A Comparison of Doxorubicin-Resistant Colon Cancer LoVo and Leukemia HL60 Cells: Common Features, Different Underlying Mechanisms. Curr. Issues Mol. Biol. 2021, 43, 163-175.
https://doi.org/10.3390/cimb43010014
AMA Style
Locatelli L, Cazzaniga A, Fedele G, Zocchi M, Scrimieri R, Moscheni C, Castiglioni S, Maier JA.
A Comparison of Doxorubicin-Resistant Colon Cancer LoVo and Leukemia HL60 Cells: Common Features, Different Underlying Mechanisms. Current Issues in Molecular Biology. 2021; 43(1):163-175.
https://doi.org/10.3390/cimb43010014
Chicago/Turabian Style
Locatelli, Laura, Alessandra Cazzaniga, Giorgia Fedele, Monica Zocchi, Roberta Scrimieri, Claudia Moscheni, Sara Castiglioni, and Jeanette A. Maier.
2021. "A Comparison of Doxorubicin-Resistant Colon Cancer LoVo and Leukemia HL60 Cells: Common Features, Different Underlying Mechanisms" Current Issues in Molecular Biology 43, no. 1: 163-175.
https://doi.org/10.3390/cimb43010014
APA Style
Locatelli, L., Cazzaniga, A., Fedele, G., Zocchi, M., Scrimieri, R., Moscheni, C., Castiglioni, S., & Maier, J. A.
(2021). A Comparison of Doxorubicin-Resistant Colon Cancer LoVo and Leukemia HL60 Cells: Common Features, Different Underlying Mechanisms. Current Issues in Molecular Biology, 43(1), 163-175.
https://doi.org/10.3390/cimb43010014